Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Applying the arts to wild little hearts

When author Maurice Sendak first sketched out the story of a rambunctious little boy sent to his room without supper, there’s no way he could have known his rollercoaster tale of childhood imagination would still be speaking to the hearts of wild young things more than six decades on.

Breakthrough in antibiotic discovery opens Pandora's Box

Although a staple of modern medicine, the benefits of antibiotics are waning thanks to overuse and the increasing ability of bacteria to dodge them – known as antimicrobial resistance (AMR).

Early learning on the move: Play Active to boost kids’ energetic play nationwide

More than 80,000 Australian children are expected to benefit from a trial being rolled out to 700 childcare centres across the country that aims to boost declining physical activity levels.

Partnership expands Aboriginal kids’ lung health program across Western Australia

A program aimed at raising awareness of the dangers of a chronic wet cough in Aboriginal children has been extended to 14 remote and regional towns in Western Australia - thanks to a partnership between The Kids Research Institute Australia and Cystic Fibrosis WA.

Healing airways so kids with asthma can breathe better

An exciting study is investigating whether a new therapeutic treatment for asthma will protect young sufferers from ongoing lung damage and improve their long-term health outcomes.

Shopping for data to drive discoveries

What if researchers could shop for different data to help uncover how, when and why chronic conditions such as asthma, obesity, allergies and poor mental health develop?

Research

GAMA project

This study investigated host gene expression in response to new HIV infection.

Research

Estimating the impact of Western Australia's first respiratory syncytial virus immunisation program for all infants: A mathematical modelling study

The Australian Therapeutic Goods Administration approved the use of nirsevimab, a long-acting monoclonal antibody for the prevention of Respiratory Syncytial Virus (RSV), in November 2023. Western Australia (WA) implemented a combination of nirsevimab administration strategies designed to protect all infants starting in April 2024, before the epidemic season. We developed a dynamic transmission model to predict the impact of WA's RSV immunisation program on infant hospitalisations.

Research

Topical antibiotics for chronic suppurative otitis media

Chronic suppurative otitis media (CSOM), sometimes referred to as chronic otitis media, is a chronic inflammation and often polymicrobial infection (involving more than one micro-organism) of the middle ear and mastoid cavity, characterised by ear discharge (otorrhoea) through a perforated tympanic membrane.

Research

ORIGINS: Nutritional Profile of Children Aged One Year in a Longitudinal Birth Cohort

Dietary intake during the first year of life is a key determinant of a child's growth and development. ORIGINS is a longitudinal birth cohort study investigating factors that contribute to a 'healthy start to life' and the prevention of non-communicable diseases.